HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Cohort
Cadonilimab plus chemotherapy shows 72.5% ORR in 51 patients with cervical cancer
New Cervical Cancer Drug Shrinks Tumors In Early Real World Tests
This prospective observational cohort study enrolled 51 patients with cervical cancer receiving cadonilimab (≥2 cycles) with chemotherapy, w…
A new cervical cancer drug shows promising results in early real-world tests, shrinking tumors for most patients while keeping side effects …
Frontiers
Apr 27, 2026
Oncology
Cohort
Histology-derived gene-expression signatures predict distant recurrence-free interval and chemotherapy benefit in early breast cancer cohorts
New Tool Predicts Breast Cancer Recurrence From Old Slides
This multi-cohort study evaluated histology-derived gene-expression signatures from routine hematoxylin and eosin slides compared with clini…
A simple AI analysis of old biopsy slides can now predict which breast cancer patients face higher risk of recurrence and who truly benefits…
medRxiv
Apr 24, 2026
Oncology
Sys. Review
Review of immunotherapy innovations for triple-negative breast cancer survival
New Hope for Tough-to-Treat Breast Cancer
This narrative review examines immunotherapy innovations, including immune checkpoint inhibitors and combination strategies, for patients wi…
This approach may change how doctors treat one of the hardest forms of breast cancer.
Frontiers
Apr 23, 2026
Allergy & Immunology
Sys. Review
Review of combination strategies for digestive system tumors including gastric and colorectal cancer
Unlocking New Ways to Beat Drug Resistance in Digestive Cancers
This review examines theoretical approaches to enhance efficacy in patients with digestive system tumors, including gastric, colorectal, and…
Researchers are finding better ways to combine treatments so drugs keep working longer.
Frontiers
Apr 23, 2026
Nutrition & Obesity Medicine
Cohort
Breast cancer chemotherapy associated with taste alterations and dietary changes in Italian cohort
Chemo Taste Changes: Patients Feel More Than Tests Detect
This prospective observational cohort study evaluated female patients with breast cancer undergoing chemotherapy at Candiolo Cancer Institut…
New research shows chemotherapy changes how food tastes, but standard tests might not catch it all.
Frontiers
Apr 22, 2026
Oncology
Cohort
Medicinal mushrooms may support immune function and tolerability in cancer patients receiving chemotherapy
Mushrooms Might Help Your Body Fight Cancer
This narrative review examined medicinal mushrooms (Trametes versicolor, Lentinula edodes, Grifola frondosa, Ganoderma lucidum, Cordyceps sp…
Adding specific mushroom extracts to chemotherapy could help your body handle treatment better and fight cancer more effectively.
Frontiers
Apr 21, 2026
Drug Pipeline
Meta-analysis
Network meta-analysis of immunotherapy for persistent, recurrent, or metastatic cervical cancer
Do newer immunotherapies help people with advanced cervical cancer live longer?
This systematic review and network meta-analysis of phase III trials synthesized evidence on first-line immunotherapy regimens for persisten…
Newer immunotherapy combinations help people with advanced cervical cancer live longer and shrink tumors better than standard chemotherapy a…
Frontiers
Apr 19, 2026
Oncology
Phase III
SCOPE platform predicts outcomes for metastatic colorectal and pancreatic cancers using organoid screening
A Lab-Built Tumor Test May Predict If Cancer Drugs Will Work
This preclinical platform development study utilized a machine learning system integrating patient-derived organoids and clinical data to pr…
A platform called SCOPE uses tiny lab-grown copies of a patient's tumor to predict — before a large trial even starts — whether a cancer dru…
medRxiv
Apr 18, 2026
Oncology
RCT
Combining chemotherapy, immunotherapy, and high-dose radiation achieved remission in a patient with cervical esophageal adenocarcinoma
Rare throat cancer vanishes after bold three-pronged treatment
This case report describes a 39-year-old male with cervical esophageal adenocarcinoma treated with standard chemotherapy and immunotherapy c…
A 39-year-old man with rare throat cancer reached complete remission after doctors combined chemo, immunotherapy, and high-dose radiation.
Frontiers
Apr 15, 2026
Oncology
RCT
Intravenous vitamin C did not reduce gastrointestinal toxicities but attenuated platelet decline in nasopharyngeal carcinoma patients
Intravenous vitamin C may help protect platelets during cancer treatment in Thailand
A randomized, double-blind, placebo-controlled trial in Thailand assessed 2 g of intravenous vitamin C prior to chemotherapy in patients wit…
Intravenous vitamin C helped slow platelet loss in Thai cancer patients undergoing treatment, though it did not reduce common side effects l…
Apr 14, 2026
Oncology
Meta-analysis
Network meta-analysis of adjuvant chemotherapy regimens for early-stage breast cancer identifies optimal dosing sequences and safety profiles
New analysis suggests specific chemo schedules may improve outcomes for early breast cancer patients
This network meta-analysis evaluated Phase II and Phase III trials involving 17,187 women with early-stage breast cancer receiving adjuvant…
A new analysis of 17,187 women with early breast cancer suggests specific chemo schedules may improve outcomes and reduce side effects.
Apr 9, 2026